Gene Therapy For Osteoarthritis of the Knee – Clinical Trial
Mike Clayman, CEO of Flexion, a biopharmaceutical company focusing on musculoskeletal conditions, talks about the preclinical studies on FX201, a locall...
5307 articles
Mike Clayman, CEO of Flexion, a biopharmaceutical company focusing on musculoskeletal conditions, talks about the preclinical studies on FX201, a locall...
Chris DeRienzo, Chief Medical Officer at Cardinal Analytx Solutions, a predictive analytics company, discusses their mission to use advanced machine lea...
Roshini Raj, a board-certified gastroenterologist and television personality, talks about exocrine pancreatic insufficiency (EPI), the symptoms, and how...
Returning guest, President, and CEO of the Muscular Dystrophy Association (MDA), Lynn O’Connor Vos, discusses highlights from the Clinical and Scienti...
Himanshu Brahmbhatt, co-CEO of EnGeneIC, a biopharma company, talks about the company's development of a first-in-class cyto-immunotherapy platform for ...
Joan von Feldt and Shanelle Gabriel, lupus warrior discusses what lupus is and tips to help manage the disease. Learn more on Health Professional Radio.
Karin Ried, Australian Researcher and expert in Kyolic Aged Garlic Extract, discusses the results of a recently published clinical trial that shows that...
Financial Planner, Chad Chubb discusses his niche market HENRYs (High Earning Not Rich Yet) for individuals who struggle with massive student loan debts.
ViiV Healthcare and the Latino Commission on AIDS collaborated on a study to explore strategies to improve healthcare services and HIV treatment adheren...
Jens Hillengass of Roswell Park Comprehensive Cancer Center, discusses the newly FDA approved immunotherapy combination, Empliciti® (elotuzumab), to tr...